Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A broad market index fund offers simple diversification and low costs, making it a practical choice for retirement portfolios seeking steady growth.
28,528 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
When a big insurer surprises with profit growth as tech stocks stumble, the market takes notice. This piece breaks do...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
When a CEO sells a sizable block of stock, investors take notice. This article breaks down the numbers behind imax so...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
In May, a calmer approach can shine. This article highlights two dividend stocks that are no-brainer buys for conserv...
May brings optimism for growth investors. In this guide, I share my favorite growth stocks to buy in May, why they fi...
Realty Income raised dividend for the 113th consecutive time, but the stock trades at rich valuations with rising lev...
Indonesian telecoms chief Vikram Sinha is leading Indosat into sovereign AI territory, threading local-language model...
Nvidia unveiled a large stake in Iren to support a 5GW global AI factory plan, sending Iren’s stock higher even as th...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...